Journal ArticleOPEN ACCESS

Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody

  • Lurati A
  • Bertani L
  • Re K
  • et al.
Case Reports in Rheumatology (2012) 2012 1-2
DOI: 10.1155/2012/639612
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, affecting preferentially medium-large size arteries. Here we report a case of a female with a diagnosis of GCA based on temporal artery biopsy, successfully treated with tocilizumab, a humanized anti-interleukin-6 receptor antibody.

Cite

CITATION STYLE

APA

Lurati, A., Bertani, L., Re, K. A., Marrazza, M., Bompane, D., & Scarpellini, M. (2012). Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody. Case Reports in Rheumatology, 2012, 1–2. https://doi.org/10.1155/2012/639612

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free